Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Submitted by
admin
on June 3, 2014 - 11:03am
Source:
Yahoo/AP
News Tags:
Teva Pharmaceuticals
Labrys
M&A
Headline:
Teva Pharma to build pain treatment portfolio with $200M deal for Labrys Biologics
Do Not Allow Advertisers to Use My Personal information
